A detailed history of Lazard Asset Management LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Lazard Asset Management LLC holds 96 shares of MGTX stock, worth $622. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 251 61.75%
Holding current value
$622
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.88 - $5.23 $601 - $810
-155 Reduced 61.75%
96 $0
Q2 2024

Aug 14, 2024

SELL
$4.21 - $5.81 $14,591 - $20,137
-3,466 Reduced 93.25%
251 $1,000
Q1 2024

May 14, 2024

SELL
$5.78 - $7.33 $11,808 - $14,975
-2,043 Reduced 35.47%
3,717 $21,000
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $799 - $1,587
222 Added 4.01%
5,760 $40,000
Q3 2023

Nov 14, 2023

BUY
$4.79 - $7.19 $967 - $1,452
202 Added 3.79%
5,538 $27,000
Q2 2023

Aug 14, 2023

BUY
$5.19 - $8.07 $845 - $1,315
163 Added 3.15%
5,336 $35,000
Q1 2023

May 15, 2023

SELL
$5.04 - $8.6 $7,267 - $12,401
-1,442 Reduced 21.8%
5,173 $26,000
Q4 2022

Feb 14, 2023

SELL
$5.8 - $8.98 $17,162 - $26,571
-2,959 Reduced 30.91%
6,615 $43,000
Q3 2022

Nov 14, 2022

BUY
$7.55 - $11.25 $6,357 - $9,472
842 Added 9.64%
9,574 $80,000
Q2 2022

Aug 09, 2022

BUY
$6.8 - $14.23 $25,724 - $53,832
3,783 Added 76.44%
8,732 $66,000
Q1 2022

May 13, 2022

BUY
$13.42 - $23.38 $66,415 - $115,707
4,949 New
4,949 $68,000
Q1 2021

May 14, 2021

SELL
$13.84 - $17.8 $20,607 - $26,504
-1,489 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$12.4 - $17.6 $18,463 - $26,206
1,489 New
1,489 $22,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.